Christopher R. Shuhart, MD MHA (he/him/his)
Medical Director
Swedish Bone Health and Osteoporosis
Disclosure(s): No financial relationships to disclose
Angela M. Cheung, MD, PhD, FRCPC (she/her/hers)
Professor of Medicine
University of Toronto, CANADA, Canada
Disclosure(s): No relevant disclosure to display
Ranjodh Gill, MD FACP CCD
Professor
Virginia Commonwealth University Health System
Disclosure(s): No financial relationships to disclose
Bjoern Buehring, MD, CCD
Department Head
Bergisches Rheuma-Zentrum, Germany
Disclosure(s): Alexion: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing), Other (Ongoing); Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing), Other (Ongoing); medimaps group: Other (Ongoing); Theramex: Consulting Fee (e.g., Advisory Boards) (Ongoing); UCB: Consulting Fee (e.g., Advisory Boards) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing), Other (Ongoing)
Steven Petak, MD, JD (he/him/his)
Division Head and Clinical Service Chief Endocrinology
Houston Methodist Hospital
Disclosure(s): No financial relationships to disclose
John T. Schousboe, MD, PhD, CCD
Director, Park Nicollet Bone Densitometry Center; Consultant Rheumatologist, Park Nicollet Clinic; Research Investigator, HealthPartners Institute
Park Nicollet Clinic
Disclosure(s): No financial relationships to disclose
Robert Adler, MD
Chief Endocrinology, Professor
Richmond Veterans Affairs Medical Center
Disclosure(s): Radius Health: Contracted Research (PI’s must provide disclosure in this category) (Terminated, December 31, 2021)
John J. Carey, MBBChBAO, MS, CCD
Professor in Medicine
University of Galway, Ireland, Ireland
Disclosure(s): Abbvie, Ireland: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Amgen Ireland and Europe: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Contracted Research (PI’s must provide disclosure in this category) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Eli Lilly, Ireland: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Nordic Pharma: Other (Terminated, January 30, 2023); Pfizer Ireland, UK, Europe, Brazil and Canada: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023)
Manju Chandran, MD, FACP, FACE, FAMS (she/her/hers)
Senior Consultant and Director
Singapore General Hospital
Disclosure(s): No financial relationships to disclose
Anita Colquhoun, RTNM, MRT(N), CDT
Charge Technologist
Women's College Hospital, Canada
Disclosure(s): No financial relationships to disclose
Ghada El-Hajj Fuleihan, MD, MPH, CCD
Professor of Medicine
American University of Beirut
Disclosure(s): ABIOGEN: Other (Terminated, September 4, 2022)
E. Michael Lewiecki, MD, FACP, FACE, CCD (he/him/his)
Director
New Mexico Clinical Research & Osteoporosis Center
Disclosure(s): Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)
Nicholas Pocock, MB, BS, MD, FRACP (he/him/his)
Senior Staff Specialist
St Vincent's Hospital, Darlinghurst, Sydney, Australia
Disclosure(s): No financial relationships to disclose
Andrea J. Singer, MD, FACP CCD (she/her/hers)
Director of Women’s Primary Care, Director of the Bone Densitometry Program, and Medical Director of the Fracture Liaison Service focusing on secondary fracture prevention
MedStar Georgetown University Hospital in Washington, DC
Disclosure(s): No relevant disclosure to display
Auryan Szalat, MD (he/him/his)
Director of the Osteoporosis Center
Hadassah Medical Center , Israel
Disclosure(s): No financial relationships to disclose
Linsey U. Gani, MBBS FRACP MPH (she/her/hers)
Senior Consultant
Changi General Hospital. Singapore , Singapore
Disclosure(s): No financial relationships to disclose